Navigation Links
Ireland Cancer Center researcher finds most triple-negative breast cancers express muc-1 target
Date:12/12/2008

CLEVELAND: Research out of the Ireland Cancer Center of University Hospitals Case Medical Center has found that the vast majority of triple negative breast cancers express the MUC-1 target. This first-of-its-kind finding, presented today at the San Antonio Breast Cancer Symposium, has paved the way for an upcoming vaccine trial for patients with early stage triple negative breast cancer that could potentially prevent recurrence of this aggressive type of breast cancer.

Joseph Baar, MD, PhD, Director of Breast Cancer Research at the Ireland Cancer Center, and colleagues analyzed 53 tumors and determined that 92 percent of them expressed MUC-1. These findings support their theory that this MUC-1 protein on breast cancer cells could be a target for a novel vaccine using the patient's immune system to target and kill cancer cells.

Dr. Baar has received a prestigious grant from the National Cancer Institute and the Avon Foundation to begin the vaccine trial in January 2009 for women with early stage triple negative breast cancer to see if this vaccine can raise their immune response against MUC-1. If it does, then a later study would be undertaken to determine whether the generation of such an immune response leads to an increase in patients' relapse-free survival rates, thereby preventing recurrence. The vaccine will be administered following standard therapy of surgery, radiation and chemotherapy.

"This vaccine trial has the potential to rev up patients' immune response to the MUC-1 protein and shut down the tumor's ability to grow," says Dr. Baar. "Women with this aggressive triple negative breast cancer have an increased risk of recurrence and we are hoping to provide them with protection against the return of this deadly disease. Our findings that have been presented at the San Antonio Breast Symposium provide us a strong basis for this trial."

Triple negative breast cancer is a highly aggressive form which comprises 10-1
'/>"/>

Contact: Alicia Reale
alicia.reale@UHhospitals.org
216-844-5158
University Hospitals of Cleveland
Source:Eurekalert

4

GOOD

Page: 1 2

Related biology news :

1. Ireland Cancer Center researchers advance stem cell gene therapy
2. For good or ill Ireland gains another mammal species
3. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. ESF EURYI award winner aims to stop cancer cells reading their own DNA
6. Protein chatter linked to cancer activation
7. Newly created cancer stem cells could aid breast cancer research
8. Western diet linked to increased risk of colon cancer recurrence
9. Obesity and lack of exercise could enhance the risk of pancreatic cancer
10. Low levels of key protein may indicate pancreatic cancer risk
11. Birth records hold pancreatic cancer clue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ong held secrets of the earth,s history locked in ... very little information on the environments that ... of years. Now, a team of researchers from nine in... tune of $10 million dollars by the National Scien...ngs literally. These scientists will drill throug...
(Date:11/23/2009)...-associated strain of the deadly superbug MRSAan i... antibioticsposes a far greater health threat than...tals, according to a study in the December issue o...eat is easily picked up in fitness centers, school...verall burden of MRSA within hospitals, the report...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Custom Spine Announces New Board of Directors and CFO 52778 1Custom Spine Announces New Board of Directors and CFO 52778 2Olympus Managed Health Care Receives Third Party Administrative License in State of Florida 52776 1Northside Medical Center Nurses Reach Tentative Agreement with Forum Health 52774 1
...easing ventilation within aircraft cabins can redu...ggests a review published in this week,s issue of ...Centre, MA, USA) and colleagues reviewed data from...uring commercial air travel. They found that while...r the spread of pathogens carried by passengers or...
...h is more likely to happen - you being in a car wr...red that cars are greater killers win a free trip ... A&M University professor. Your chances of bei... lunch, says John McEachran, a professor of wildli... years. , Worldwide, about one million people a ye...
...ou thought the sleep-deprived months with your new...iller whale. , Reporting in the June 30 edition o...Affairs neuroscientists report a developmental pat... is unique from other mammals, with calves of both...month. , The mother also has minimal sleep during ...
Other Biology News:Aircraft Cabin Ventilation Influences The Transmission Of Diseases In-flight 2New HIV drug candidate developed in Sweden 2Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development 2
(Date:11/25/2009)...wswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasd...harm.D., president and chief executive officer, wi... Care Conference. , ,Presentation details are as ...nference,Date: Tuesday, December 1, 2009,Time...ork Palace Hotel, New York, NY,Webcast: <a href...
(Date:11/24/2009)...to also Visit Detroit , (... French Ambassador for International Investment, a..., , , , ,What: Ambassador Appia is available to m...iatives adopted by France to further develop the f...tion and development., , ,When: Available for Inte...
(Date:11/24/2009)...ario, Nov. 24 Dow AgroSc...assets of Hyland Seeds, a division of Thompsons Li... Seeds will further expand Dow AgroSciences, curre...ntroduction of SmartStax(TM) in 2010 and Dow...in corn in 2012. The transactional close is expect...
(Date:11/24/2009)...e employment grew by 29,000 jobs in October, and ...growth during the U.S. recession. However, clinics...alth systems are coming closer to having to actual...rators. , (Vocus) Novembe...wing in October despite the shedding of jobs in mo...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...JAVIK, Iceland, and ALAMEDA, California, April 23,...ration (NASDAQ: CRA ) today announced the signing...ra non-exclusive worldwide licenses to deCODE,s,ge...scular and metabolic,diseases, including heart att...iabetes (T2D). These markers can be incorporated i...
...GCHUN, China and LOS ANGELES, April 23 /PRNewswire...nue Increased 28.6% to $14.1 Million, with Net, ..., - 2008 Revenues Increased 23.5% to $59.1 Mill...ed 340 Basis Points to 20.1%, - 2008 Net Income...of, $0.13, - 2008 Cash Flow from Operation...
...omarker predicts likelihood of recurrence and long...nts; Further strengthens Company,s breast cancer m..., Inc. , (Nasdaq: CLRT ), a premier anatomic pa...r pathologists, oncologists and the pharmaceutical...d an exclusive intellectual property license from ...
Other Biology Technology:deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 2deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 3deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 4deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 5deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 6deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 2Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 3Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 4Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 5
... bespoke, cost-effective solutions for complex pro...l use our extensive expertise and experience to he... uniquely, you may: , , do additional wor...fer all methodology to your own lab , transfe...
...lubility Service, We deliversoluble protein or No...st soluble protein results , 24 solubility optimiz... Powerful results on your most insoluble clones ,...SOS) uses proprietary tools and know-how recently ...
...l at its Best: DASGIPs Process Control integrates ... Changes & comprehensive documentation for cultiva... pH, dissolved oxygen, temperature and agitation s...s, e.g. constant or scheduled media flow, are cha...
...ng is a commonly used technique for studying prote...amples are electrophoresed on SDS-PAGE and transfe..., where they are probed with specific antibodies. ...w reuse of Southern and Northern blots, it has bee...
Biology Products: